Cancer chemoprevention by polyphenols in green tea and artichoke

Advances in Experimental Medicine and Biology

Volumn 401, Issue , 1996, Pages 35-50

  Agarwal, Rajesh ^a   Mukhtar, Hasan ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPHENOL DERIVATIVE; SILYMARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICHOKE; CANCER GROWTH; CANCER INHIBITION; CANCER MODEL; CANCER PREVENTION; CARCINOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; MOUSE; NONHUMAN; PLANT; PRIORITY JOURNAL; PROSTATE CANCER; TEA;

ANIMALIA; CYNARA SCOLYMUS; SCOLYMUS;

EID: 0029813096     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0399-2_4     Document Type: Conference Paper

References (107)

1. B.N. Ames, L.S. Gold, W.C. Willett, The causes and prevention of cancer. Proc Natl Acad Sci USA 92: 5258-5265 (1995).
2. J. DiGiovanni, Multistage carcinogenesis in mouse skin, Pharmac Ther 54: 63-128 (1992).
3. R. Agarwal, H. Mukhtar, Cutaneous chemical carcinogenesis. In Pharmacology of the skin. U. Mukhtar (Ed.), CRC Press, Boca Raton, pp. 371-387, 1991.
4. H.C. Pitot, Y.P. Dragan, Facts and theories concerning the mechanisms of carcinogenesis, FASEB J 5: 2280-2286 (1991).
5. G.D. Stoner, H. Mukhtar, Polyphenols as cancer chemopreventive agents, J Cellular Biochem (Suppl) 22: 169-180 (1995)
6. C.W. Boone, G.J. Kelloff, W.E. Malone, Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials. Cancer Res 50: 2-9 (1990).
7. M.A. Morse, G.D. Stoner, Cancer chemoprevention: Principles and prospects, Carcinogenesis 14: 1737-1746 (1993).
8. H. Sumiyoshi, M.J. Wargovich, Chemoprevention of 1,2-dimethylhydrazine-induced colon cancer in mice by naturally occurring organosulfur compounds. Cancer Res 50: 5084-5087 (1990).
9. H. Wei, L. Tye, E. Bresnick, D.F. Birt, Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res 50: 499-502 (1990).
10. H.F. Stich, The beneficial and hazardous effects of simple phenolic compounds. Mutation Res 259: 307-324 (1991).
11. L.W. Wattenberg, Inhibition of carcinogenesis by naturally occurring and synthetic compounds. In Antimutagenesis and Anticarcinogenesis, Mechanisms H. Y. Kuroda, D.M. Shankel and M.D. Waters (Eds.), Plenum Publishing Corp, New York, pp. 155-166, 1990.
12. H. Mukhtar, Z.Y. Wang, S.K. Katiyar, R. Agarwal, Tea components: Antimutagenic and anticarcinogenic effects. Preventive Medicine 21: 351-360 (1992).
13. H. Mukhtar, S.K. Katiyar, R. Agarwal, Green tea and skin - anticarcinogenic effects. J Invest Dermatol 102: 3-7 (1994).
14. C.S. Yang, Z.Y. Wang, Tea and cancer, J Natl Cancer Insti 85: 1038-1049 (1993).
15. T. Yaminishi, I. Tomita, Proceedings of the International Symposium on Tea Sciences, 1992.
16. T. Kada, K. Kaneko, S. Matsuzaki, T. Matsuzaki, Y. Hara, Detection and chemical identification of natural bio-antimutagens. A case of green tea factor. Mutation Res 150: 127-132 (1985).
17. S.J. Chcng, C.T. Ho, H.Z. Lou, Y.D. Bao, Y.Z. Jian, M.H. Li, Y.N. Gao, G.F. Zhu, J.F. Bai, S.P. Guo, X.Q. Li, A preliminary study on the antimutagenicity of green tea amioxidants. Acta Biol Exp Sinica 19: 427-431 (1986).
18. R.R. Mohan, S.G. Khan, R. Agarwal, H. Mukhtar, Testosterone induces ornithine decarboxylase (ODC) activity and mRNA expression in human prostate carcinoma cell line LNCaP: inhibition by green tea. Proc Amer Assoc Cancer Res 36:274 (1995).
19. P.T. Strickland, Tumor induction in Sencar mice in response to ultraviolet radiation, Carcinogenesis 3: 1487-1489 (1982).
20. H. Mukhtar, (Ed.) Skin Cancer: Mechanisms and Human Relevance, CRC Press, Boca Raton, FL, 1995.
21. A.H. Conney, Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: GHA Clowes Memorial Lecture, Cancer Res 42: 4875-4917 (1982).
22. H.N. Ananthaswamy, W.E. Pierceall, Molecular mechanisms of ultraviolet radiation carcinogenesis. Photochem Photobiol 52: 1119-1136 (1990).
23. A.J. Nataraj, J.C. Trent II, H.N. Ananthaswamy, p53 gene mutations and photocarcinogenesis, Photochem Photobiol 62: 218-230 (1995).
24. R. Agarwal, H. Mukhtar, Oxidative stress in skin chemical carcinogenesis. In Oxidative stress in dermatology (Fuchs, J. and Packer, L. eds), Marcel Dekker, Inc, New York, NY, pp 207-241, 1993.
25. S.G. Khan, R.R. Mohan, S.K. Katiyar, G.S. Wood, D.R. Bickers, H. Mukhtar, R. Agarwal, Mutations in ras oncogenes are rare events in ultraviolet B radiation induced mouse skin tumorigenesis, Mol carcinogenesis, In Press, 1995.
26. J.P.G. Volpe, L. Wang, J.H. Epstein, T.J. Slaga, J.E. Cleaver, Absence of ras mutations in UV-induced skin tumors in mice. Proc Am Assoc Cancer Res 36:187 (1995).
27. Z.Y. Wang, M. Das, D.R. Bickers, H. Mukhtar, Interaction of epicatechins derived from green tea with rat hepatic cytochrome P-450, Drug Metab Dispos 16: 98-103 (1988).
28. Z.Y. Wang, W.A. Khan, D.R. Bickers, H. Mukhtar, Protection against polycyclic aromatic hydrocarbon-induced skin tumor initiation in mice by green tea polyphenols. Carcinogenesis 10: 411-415 (1989).
29. Z.Y. Wang, S.J. Cheng, Z.C. Zhou, M. Athar, W.A. Khan, D.R. Bickers, H. Mukhtar, Antimutagenic activity of green tea polyphenols. Mutation Res 223: 273-289 (1989).
30. S.G. Khan, S.K. Katiyar, R. Agarwal, H. Mukhtar, Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention, Cancer Res 52: 4050-4052 (1992).
31. Q. Liu, Y. Wang, K.A. Crist, M.T. Huang, A. Conney, M. You, Analysis of p53 and H-ras mutations in UV- and UV-green tea-induced tumorigenesis in the skin of SKH-1 mice. Proc Am Assoc Cancer Res 36:591 (1995).
32. Z.Y. Wang, R. Agarwal, D.R. Bickers, H. Mukhtar, Protection against ultraviolet B radiation-induced photocarcinogenesis in hairless mice by green tea polyphenols, Carcinogenesis 12: 1527-1530 (1991).
33. M.-T. Huang, C.-T. Ho, Z.Y. Wang, T. Ferraro, T. Finnegan-Olive, Y.-R. Lou, J.M. Mitchell, J.D. Laskin, H. Newmark, C.S. Yang, A.H. Conney, Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin, Carcinogenesis 13: 947-954 (1992).
34. W.A. Khan, Z.Y. Wang, M. Athar, D.R. Bickers, H. Mukhtar, Inhibition of the skin tumorigenicity of (+)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10- tetrahydrobenzo(a)pyrene by tannic acid, green tea polyphenols and quercetin in SENCAR mice. Cancer Lett 42: 7-12 (1988).
35. S.K. Katiyar, R. Agarwal, Z.Y. Wang, A.K. Bhatia, H. Mukhtar,(-)-Epigallocatechin-3-gallate in Camellia sinensis leaves from Himalayan region of Sikkim: inhibitory effects against biochemical events and rumor initiation in SENCAR mouse skin, Nutr Cancer 18: 73-83 (1992).
36. Z.Y. Wang, M.-T. Huang, T. Ferraro, C.-Q. Wong, Y-R. Lou, M. Iatropoulos, C.S. Yang, A.H. Conney, Inhibitory effect of green tea in the drinking water on tumorigenesis by ultraviolet light and 12-O-tetradecanoylphorbol-13-acetate in the skin of SKH-1 mice, Cancer Res 52: 1162-1170 (1992).
37. J.-P. Perchellet, E.M. Perchellet, Antioxidants and multistage carcinogenesis in mouse skin. Free Radical Biol Med 7: 377-408 (1989).
38. H.U. Gali, E.M. Perchellet, J.-P. Perchellet, Inhibition of tumor promoter-induced ornithine decarboxylase activity by tannic acid and other polyphenols in mouse epidermis in vivo. Cancer Res 51: 2820-2825 (1991).
39. S.K. Katiyar, R. Agarwal, G.S. Wood, H. Mukhtar, Inhibition of 12-O-tetradecanoylphorbol-13-acetate-caused tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated SENCAR mouse skin by a polyphenolic fraction isolated from green tea, Cancer Res 52: 6890-6897 (1992).
40. S.K. Katiyar, R. Agarwal, S. Ekker, G.S. Wood, H. Mukhtar, Protection against 12-O-tetradecanoylphorbol-13-acetate-caused inflammation in SENCAR mouse ear skin by polyphenolic fraction isolated from green tea, Carcinogenesis 14: 361-365 (1993).
41. R. Agarwal, S.K. Katiyar, S.I.A. Zaidi, H. Mukhtar. Inhibition of tumor promoter-caused induction of ornithine decarboxylase activity in SENCAR mice by polyphenolic fraction isolated from green tea and its individual epicatechin derivatives, Cancer Res 52: 3582-3588 (1992).
42. S.K. Katiyar, C.O. Rupp, N.J. Korman, R. Agarwal, H. Mukhtar, Inhibition of 12-O-tetradecanoylphorbol-13-acetate and other skin tumor promoter-caused induction of epidermal interleukin-1α mRNA and protein expression in SENCAR mice by green tea polyphenols, J Invest Dermatol In Press, 1995.
43. R. Agarwal, S.K. Katiyar, S.G. Khan, H. Mukhtar, Protection against ultraviolet B radiation-induced effects in the skin of SKH-1 hairless mice by a polyphenolic fraction isolated from green tea, Photochem Photobiol 58: 695-700 (1993).
44. S. Yoshizawa, T. Horiuchi, H. Fujiki, T. Yoshida, T. Okuda, T. Sugimura, Antitumor Promoting Activity of (-)-Epigallocatechin Gallate, the Main Constituent of "Tannin" in Green Tea, Phytotherapy Res 1: 44-47 (1987).
45. S.K. Katiyar, R. Agarwal, H. Mukhtar, Inhibition of both stage I and stage II tumor promotion in SENCAR mice by a polyphenolic fraction isolated from green tea: Inhibition depends on the duration of polyphenols treatment, Carcinogenesis 14: 2641-2643 (1993).
46. Z.Y. Wang, M.-T. Huang, Y.-R. Lou, J.-G. Xie, K.R. Reuhl, H.L. Newmark, C.-T. Ho, C.S. Yang, A.H. Conney, Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz(a)anthracene-initiated SKH-1 mice, Cancer Res 54: 3428-3435 (1994).
47. S.K. Katiyar, R. Agarwal, H. Mukhtar, Protection against malignant conversion of chemically-induced benign skin papillomas to squamous cell carcinomas in SENCAR mice by a polyphenolic fraction isolated from green tea, Cancer Res 53: 5409-5412 (1993).
48. Z.Y. Wang, M.-T. Huang, C.-T. Ho, R. Chang, W. Ma, T. Ferraro, K.R. Reuhl, C.S. Yang, A.H. Conney, Inhibitory effect of green tea on the growth of established skin papillomas in mice, Cancer Res 52: 6657-6665 (1992).
49. Z.Y. Wang, R. Agarwal, W.A. Khan, H. Mukhtar, Protection against benzo(a)pyrene and N-nitrosodiethylamine-induced lung and forestomach tumorigenesis in A/J mice by water extracts of green tea and licorice, Carcinogenesis 13: 1491-1494 (1992).
50. Z.Y. Wang, J.Y. Hong, M.-T. Huang, K.R. Reuhl, A.H. Conney, C.S. Yang, Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea, Cancer Res 52: 1943-1947 (1992).
51. S.K. Katiyar, R. Agarwal, M.T. Zaim, H. Mukhtar, Protection against N-nitrosodiethylamine and benzo(a)pyrene-induced forestomach and lung tumorigenesis in A/J mice by green tea, Carcinogenesis 14: 849-855 (1993).
52. S.K. Katiyar, R. Agarwal, H. Mukhtar, Protective effects of green tea polyphenols administered by oral intubation against chemical carcinogen-induced forestomach and pulmonary neoplasia in A/J mice, Cancer Lett 73: 167-172 (1993).
53. Y. Xu, C.-T. Ho, S.G. Amin, C. Han, F.L. Chung, Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants, Cancer Res 52: 3875-3879 (1992).
54. Y. Fujita, T. Yamane, M. Tanaka, K. Kuwata, J. Okuzumi, T. Takahashi, H. Fujiki, T. Okuda, Inhibitory Effect of (-)-Epigallocatechin Gallate on Carcinogenesis with N-Ethyl-N'-Nitro-N-Nitrosoguanidine in Mouse Duodenum, Jpn J Cancer Res (Gann) 80: 503-505 (1989).
55. T. Yamane, N. Hagiwara, M. Tateishi, S. Akachi, M. Kim, J. Okuzumi, Y. Kitao, M. Inagake, K. Kuwata, T. Takahashi, Inhibition of azoxymethane-induced colon carcinogenesis in rat by green tea polyphenol fraction, Jpn J Cancer Res (Gann) 82: 1336-1340 (1991).
56. T. Narasiwa, Y. Fukaura, A very low dose of green tea polyphenols in drinking water prevents N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats, Jpn J Cancer Res) 84: 1007-1009 (1993).
57. Y. Xu, C. Han, The effect of Chinese tea on the occurrence of esophageal tumors induced by N-nitrosomethylbenzylamine formed in vivo, Biomed Environ Sci 3: 406-412 (1990).
58. G.D. Gao, L.F. Zhou, G. Qi, Initial study of antitumorigenesis of green tea: animal test and flow cytometry, Tumor 10: 42-44 (1990).
59. 1-induced γ-glutamyltranspepidase positive hepatocyte foci in rats, Chung Hua Chung Liu Tsa Chih 9: 109-111 (1987).
60. Y. Li, Comparative study on the inhibitory effect of green tea, coffee and levamisole on the hepatocarcinogenic action of diethylnitrosamine, Chung Hua Chung Liu Tsa Chih 13: 193-195 (1991).
61. N. Harada, F. Takabayashi, I. Oguini, Anti-promotion effect of green tea extracts on pancreatic cancer in golden hamster induced by N-nitroso-bis(2-oxopropyl)amine, Int Sympo on Tea Sci (Japan), 1991.
62. M. Hirose, T. Hoshiya, K. Akagi, M. Futakuchi, N. Ito, Inhibition of mammary gland carcinogenesis by green tea catechins and other naturally occurring antioxidants in female Sprague-Dawley rats pretreated with 7,12, dimethylbenz(a)anthracene, Cancer Lett 83: 149-156 (1994).
63. T. Yamane, T. Takahashi, K. Kuwata, K. Oya, M. Inagake, Y. Kitao, M. Suganuma, H. Fujiki, Inhibition of N-methyl-N'-nitro-N-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach, Cancar Res 55: 2081-2084 (1995).
64. C.C. Boring, T.S. Squires, T. Tong, Cancer Statistics, 1993. CA Cancer J Clin 43:7-26 (1993).
65. C.C. Boring, T.S. Squires, T. Tong, S. Montgomery, Cancer Statistics, 1994. CA Cancer J Clin 44:22-23 (1994).
66. D.G. Bostwick, G.J. Kelloff, P.T. Scardino, C.W. Boone, Chemoprevention of premalignant and early malignant lesions of the prostate, J Cellular Biochem Supplement 16H (1992).
67. C.W. Boone, G.J. Kelloff, Qualitative pathology in Chemoprevention trails: standardization and quality control of surrogate endpoint biomarker assays for colon, brest, and prostate, J Cellular Biochem Suppl 19 (1994).
68. D.G. Bostwick, H.B. Burke, T.M. Wheeler, L.W.K. Chung, R. Bookstein, T.G. Pretlow, R.B. Nagle, R. Montirino, M.M. Lieber, R.W. Veltri, W.E. Grizzel, D.J. Grignon, The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials, J Cellular Biochem Suppl 19:283-289 (1994).
69. G.K. Kelloff, C.W. Boone, J.A. Crowell, V.E. Steele, R. Lubet, L.A. Doody, Surrogate endpoint biomarkers from phase II cancer chemoprevention trials, J Cellular Biochem Suppl 19:1-9 (1994).
70. M. Pollard, P.H. Luckert, M.B. Sporn, Prevention of primary prostate cancer in Lobound-Wistar rats by N-(4-hydroxyphenyl) retinamide, Cancer Res 51:3610-3611 (1991).
71. K. Slavin, D. Kadmon, S.H. Park, P.T. Scardino, M. Anzano, M.B. Sporn, Thompson TC: Dietary fenritinide, a synthetic retinoid, decreases the tumor incidence And the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system, Cancer Res 53:4461-4465 (1993).
72. M.B. Garnick, The dilemmas of prostate cancer, Scientific American 72-81 (1994).
73. M.C. Bosland, H.C. Dreef-Van Der Meulen, S. Sukumar, P. Ofner, I. Leav, Multistage prostate carcinogenesis: The Role of Hormones, In Multistage Carcinogenesis, CC Harris, S. Hirohashi, N Ito, HC Pitot, T Sugimura (eds). Boca Raton, FL, CRC Press, pp 109-123, 1992.
74. R.K. Ross, B.E. Henderson, Do diet and andorgens alter prostate cancer risk via a common etiologic pathway? J Natl Cancer Inst 86:252-254 (1994).
75. C. Muir, J. Waterhouse, T. Mack, (eds): Cancer Incidence in Five Continents, V. Lyon IARC, 1987.
76. H. Yu, R.E. Harris, Y.T. Gao, T. Gao, E.L. Wynder, Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States, Int J Epidermiol 30:76-81 (1991).
77. E.L. Wynder, D.P. Rose , L.A. Cohen, Nutrition and prostate cancer: a proposal for dietary intervention, Nutrition and Cancer 22:1-10(1994).
78. D.P. Rose, A.P. Boyar, E.L. Wynder, International comparisons of mortality rates for cancer of the breast, ovary, prostate and colon and per capita food consumption, Cancer 58:2363-2371 (1986).
79. R.K. Rose, H. Shimizu, A. Paganini-Hill, G. Honda, Case-control studies of prostate cancer in blacks and whites in southern California, J Natl Cancer Inst 78:869-874 (1987).
80. K.J. Pienta, P.S. Esper, Risk factors for prostate cancer, Ann Intern Med 118:793-803 (1993).
81. L.J. Marton, A.E. Pegg, Polyamines as targets for therapeutic intervention, Annu Rev Pharmacol Toxicol 35:55-91 (1995).
82. M.A. Wainstein, F. He, D. Robinson, H.-J. Kung, S. Schwartz, J.M. Giaconia, N.L. Edgehouse, T.P. Pretlow, D.R. Bodner, E.D. Kursh, M.I. Resnick, A. Seftel, T.G. Pretlow, CWR22: Androgen-dependent xenograft model derived from a primary human prostatic carcinoma, Cancer Res 59:6049-6052 (1994).
83. J.S. Horoszewicz, S.S. Leong, E. Kawinski, J.P. Karr, H. Rosenthal, T.M. Chu, E.A. Mirand, G.P. Murphy, LNCaP model of human prostatic carcinoma, Cancer Res 43:1809-1818 (1983).
84. S. Kono, M. Ikeda, S. Tokudome, M. Kuratsune, A case-control study of gastric cancer and diet in Northern Kyushu, Jpn J Cancer Res 79: 1067-1074 (1988).
85. I. Oguni, K. Nasu, S. Yammamoto, T. Nomura, On the antitumor activity of fresh green tea leaf, Agric Biol Chem 52: 1879-1880 (1988).
86. IARC Monographs on the evaluation of the carcinogenic risk to humans: coffee, tea, mate, methylxanthines and methylglyoxal, International Agency for Research on Cancer Working Group, Vol. 51, 1991.
87. Y.T. Gao, J.K. McLaughlin, W.J. Blot, B.T. Ji, Q. Dai, J.F. Fraumeni, Jr., Reduced risk of esophageal cancer associated with green tea consumption, J Natl Cancer Inst 86: 855-858 (1994).
88. M.J. Lee, Z.Y. Wang, H. Li, L. Chen, Y. Sun, S. Gobbo, D.A. Balentine, C.S. Yang, Analysis of plasma and urinary tea polyphenols in human subjects, Cancer Epidemiol Biomarkers Prevention 4: 393-399 (1995).
89. J.S. Shim, M.H. Kang, Y.H. Kim, J.K. Roh, C. Roberts, I.P. Lee, Chemopreventive effect of green tea (Camellia sinensis) among cigaratte smokers, Cancer Epidemiol Biomarkers Prevention 4: 387-391 (1995).
90. K.A. Mereish, D.L. Bunner, D.R. Ragland, D.A. Creasia, Protection against microcystin-LR-induced hepatotoxicity by silymarin: biochemistry, histopathology, and lethality, Pharmaceutical Res 8:273-277 (1991).
91. H. Wagner, O. Seligmann, L. Horhammer, R. Munster, The chemistry of silymarin (silybin), the active principle of the fruits of Silybum marianum (L) Gaertn. (Carduus marianus) (L), Arzneimittelforsch 18:688-696 (1968).
92. P Letteron, G. Labbe, C. Degott, A. Berson, B. Fromenty, M. Delaforge, D. Larrey, D. Pessayre Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice, Biochem Pharmacol 39:2027-2034 (1990).
93. 4-induced liver cirrhosis by silymarin, Fundam Clin Pharmacol 3:183-191 (1989).
94. E. Bosisio, C. Benelli, O. Pirola, Effect of the flavanolignans of Silybum marianum L. on lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes, Pharmacol Res 25:147-154 (1992).
95. R. Carini, A. Comoglio, E. Albano, G. Poli, Lipid peroxidation and irreversible damage in the rat hepatocyte model. Protection by the silybin-phospholipid complex IdB 1016, Biochem Pharmacol 43:2111-2115 (1992).
96. K. Racz, J. Feher, G. Csomos, I. Varga, R. Kiss, E. Glaz, An antioxidant drug, silibinin, modulates steroid secretion in human pathological adrenocortical cells, J Endocrinol 124:341-345 (1990).
97. A. Valenzuela, R. Guerra, L.A. Videla, Antioxidant properties of the flavonoids silybin and (+)-cyanidanol-3: Comparison with butylated hydroxyanisole and butylated hydroxytoluene, Planta Medica 5:438-440 (1986).
98. A. Garrido, A. Arancibia, R. Campos, A. Valenzuela, Acetaminophen docs not induce oxidative stress in isolated rat hepatocytes: Its probable antioxidant effect is potentiated by the flavonoid silybin, Pharmacol Toxicol 69:9-12 (1991).
99. A. Comoglio, G. Leonarduzzi, R. Carini, D. Busolin, H. Basaga, E. Albano, A. Tomasi, G. Poli, P. Morazzoni, M.J. Magistretti, Studies on the antioxidant and free radical scavenging properties of IdB 1016 a new flavanolignan complex, Free Rad Res Comms 11:109-115 (1990).
100. G. Muzes, G. Deak, I. Lang, K. Nekam, P. Gergely, J. Feher, Effect of the bioflavonoid silymarin on the in vitro activity and expression of superoxide dismutase (SOD) enzyme, Acta Physiologica Hungarica 78:3-9 (1991).
101. V.E. Steele, G.J. Kelloff, B.P. Wilkinson, J.T. Arnold, Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents, Cancer Res 50:2068-2074 (1990).
102. C.J. Rudd, K.D. Suing, K. Pardo, G. Kelloff, Evaluation of potential chemopreventive agents using a mouse epidermal cell line, JB6, Proc Am Assoc Cancer Res 31: 127 (1990).
103. R.G. Mehta, R.C. Moon, Characterization of effective chemopreventive agents in mammary gland in vitro using an initiation-promotion protocol, Anticancer Res 11:593-596 (1991).
104. R. Agarwal, S.K. Katiyar, D.W. Lundgren, H. Mukhtar, Inhibitory effect of silymarin, an anti-hepatotoxic flavonoid, on 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity and mRNA in SENCAR mice, Carcinogenesis 15:1099-1103 (1994).
105. R. Agarwal, S.K. Katiyar, H. Mukhtar, Protection against tumor promotion in mouse skin by silymarin, Proc Am Assoc Cancer Res 36:593 (1995).
106. R. Agarwal, S.K. Katiyar, H. Mukhtar, Protective effects of silymarin against ultraviolet B radiation-induced tumorigenesis in SKH-1 hairless mouse skin, J Invest Dermatol 104:635 (1995).
107. R. Agarwal, S.K. Katiyar, H. Mukhtar, Protection against photocarcinogenesis in SKH-1 hairless mice by silymarin, Photochem Photobiol 61s:14s (1995).